Chapter 59
Chapter 59. Inflammation-Induced Bone Loss in the Rheumatic Diseases
Steven R. Goldring,
Steven R. Goldring
Search for more papers by this author
Steven R. Goldring,
Steven R. Goldring
Search for more papers by this author
Book Author(s):ASBMR,
Summary
This chapter contains sections titled:
Introduction
Synovial Inflammation
Rheumatoid Arthritis
Ankylosing Spondylitis
Acknowledgments
References
- Schett G 2007 Joint remodelling in inflammatory disease. Ann Rheum Dis 66(Suppl 3): iii42–iii44.
- Walsh NC, Crotti TN, Goldring SR, Gravallese EM 2005 Rheumatic diseases: The effects of inflammation on bone. Immunol Rev 208: 228–251.
- Santiago MB, Galvao V 2008 Jaccoud arthropathy in systemic lupus erythematosus: Analysis of clinical characteristics and review of the literature. Medicine (Baltimore) 87: 37–44.
- McGonagle D, Benjamin M, Marzo-Ortega H, Emery P 2002 Advances in the understanding of entheseal inflammation. Curr Rheumatol Rep 4: 500–506.
- Benjamin M, Moriggl B, Brenner E, Emery P, McGonagle D, Redman S 2004 The “enthesis organ” concept: Why enthesopa-thies may not present as focal insertional disorders. Arthritis Rheum 50: 3306–3313.
- Benjamin M, McGonagle D 2001 The anatomical basis for disease localisation in seronegative spondyloarthropathy at entheses and related sites. J Anat 199: 503–526.
- Gravallese EM, Harada Y, Wang JT, Gorn AH, Thornhill TS, Goldring SR 1998 Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 152: 943–951.
- Bromley M, Woolley DE 1984 Histopathology of the rheumatoid lesion. Identification of cell types at sites of cartilage erosion. Arthritis Rheum 27: 857–863.
- Bromley M, Woolley DE 1984 Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint. Arthritis Rheum 27: 968–975.
- Jimenez-Boj E, Nobauer-Huhmann I, Hanslik-Schnabel B, Dorotka R, Wanivenhaus AH, Kainberger F, Trattnig S, Axmann R, Tsuji W, Hermann S, Smolen J, Schett G 2007 Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis. Arthritis Rheum 56: 1118–1124.
- Redlich K, Hayer S, Ricci R, David J, Tohidast-Akrad M, Kollias G, Steiner G, Smolen JS, Wagner EF, Schett G 2002 Osteoclasts are essential for TNF-alpha-mediated joint destruction. J Clin Invest 110: 1419–1427.
- Pettit AR, Ji H, von Stechow D, Muller R, Goldring SR, Choi Y, Benoist C, Gravallese EM 2001 TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol 159: 1689–1699.
- Li P, Schwarz EM, O'Keefe RJ, Ma L, Boyce BF, Xing L 2004 RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis. J Bone Miner Res 19: 207–213.
- Romas E, Bakharevski O, Hards DK, Kartsogiannis V, Quinn JM, Ryan PF, Martin TJ, Gillrspie MT 2000 Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis. Arthritis Rheum 43: 821–826.
- Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliot R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogach ER 1999 Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402: 304–309.
- Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, Goldring SR 2000 Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 43: 250–258.
- Romas E, Gillespie MT, Martin TJ 2002 Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone 30: 340–346.
- Redlich K, Hayer S, Maier A, Dunstan C, Tohidast-Akrad M, Lang S, Turk B, Pietschmann P, Woloszczuk W, Haralambous S, Kollias G, Steiner G, Smolen J, Schett G 2002 Tumor necrosis factor-α-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. Arthritis Rheum 46: 785–792.
- Pettit AR, Walsh NC, Manning C, Goldring SR, Gravallese EM 2006 RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis. Rheumatology (Oxford) 45: 1068–1076.
- van der Heide D, Cohen S, Sharp JT, Ory P, Zhou L, Tsuji W 2007 Denosumab inhibits RANKL, reducing progression of the total Sharp score and bone erosions in patients with rheumatoid arthritis. Arthritis Rheum 56: S299.
- Jarrett SJ, Conaghan PG, Sloan VS, Papanastasiou P, Ortmann CE, O'Connor PJ, Grainger AJ, Emery P 2006 Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis. Arthritis Rheum 54: 1410–1414.
- Goldring SR, Gravallese EM 2004 Bisphosphonates: Environmental protection for the joint? Arthritis Rheum 50: 2044–2047.
- Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, Korb A, Smolen J, Hoffman M, Scheinecker C, van der Heide D, Landewe R, Lacey D, Richards WG 2007 Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13: 156–163.
- Goldring SR, Goldring MB 2007 Eating bone or adding it: The Wnt pathway decides. Nat Med 13: 133–134.
- Stewart A, Mackenzie LM, Black AJ, Reid DM 2004 Predicting erosive disease in rheumatoid arthritis. A longitudinal study of changes in bone density using digital X-ray radiogrammetry: A pilot study. Rheumatology (Oxford) 43: 1561–1564.
- Shimizu S, Shiozawa S, Shiozawa K, Imura S, Fujita T 1985 Quantitative histologic studies on the pathogenesis of periarticular osteoporosis in rheumatoid arthritis. Arthritis Rheum 28: 25–31.
- Orstavik RE, Haugeberg G, Uhlig T, Mowinckel P, Falch JA, Halse JI, Kvein TK 2005 Incidence of vertebral deformities in 255 female rheumatoid arthritis patients measured by morphometric X-ray absorptiometry. Osteoporos Int 16: 35–42.
- Orstavik RE, Haugeberg G, Mowinckel P, Hoiseth A, Uhlig T, Falch JA, Halse JI, McCloskey E, Kvein TK 2004 Vertebral deformities in rheumatoid arthritis: A comparison with population-based controls. Arch Intern Med 164: 420–425.
- Lodder MC, de Jong Z, Kostense PJ, Molenaar ET, Staal K, Voskuyl AE, Hazes JM, Dijkmans BA, Lema WF 2004 Bone mineral density in patients with rheumatoid arthritis: Relation between disease severity and low bone mineral density. Ann Rheum Dis 63: 1576–1580.
- Haugeberg G, Orstavik RE, Kvien TK 2003 Effects of rheumatoid arthritis on bone. Curr Opin Rheumatol 15: 469–475.
- Forslind K, Keller C, Svensson B, Hafstrom I 2003 Reduced bone mineral density in early rheumatoid arthritis is associated with radiological joint damage at baseline and after 2 years in women. J Rheumatol 30: 2590–2596.
- Compston JE, Vedi S, Croucher PI, Garrahan NJ, O'Sullivan MM 1994 Bone turnover in non-steroid treated rheumatoid arthritis. Ann Rheum Dis 53: 163–166.
- Gough A, Sambrook P, Devlin J, Huissoon A, Njeh C, Robbins S, Nguyen T, Emery P 1998 Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis. J Rheumatol 25: 1282–1289.
- Garnero P, Landewe R, Boers M, Verhoeven A, Van Der Linden S, Christgau S, van der Heijde D, Boonen A, Geusens P 2002 Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: The COBRA study. Arthritis Rheum 46: 2847–2856.
- Vis M, Havaardsholm EA, Haugeberg G, Uhlig T, Voskuyl AE, van de Stadt RJ, Dijkmans BA, Woolf AD, Kvein TK, Lems WF 2006 Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis. Ann Rheum Dis 65: 1495–1499.
- Seriolo B, Paolino S, Sulli A, Ferretti V, Cutolo M 2006 Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis. Ann N Y Acad Sci 1069: 420–427.
- Geusens PP, Landewe RB, Garnero P, Chen D, Dunstan CR, Lems WF, Stinissen P, vander Heijde DM, van der Linden S, Boers M 2006 The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction. Arthritis Rheum 54: 1772–1777.
- Braun J, Bollow M, Neure L, Seipelt E, Seyrekbasan F, Herbst H, Eggens U, Distler A, Sieper J 1995 Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 38: 499–505.
- Lories RJ, Derese I, Ceuppens JL, Luylen FP 2003 Bone morphogenetic proteins 2 and 6. expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis. Arthritis Rheum 48: 2807–2818.
- Franck H, Ittel T 2000 Serum osteocalcin levels in patients with psoriatic arthritis: An extended report. Rheumatol Int 19: 161–164.
- Will R, Palmer R, Bhalla AK, Ring F, Calin A 1989 Osteoporosis in early ankylosing spondylitis: A primary pathological event? Lancet 2: 1483–1485.
